Page last updated: 2024-09-03

imatinib mesylate and Sarcoma, Epithelioid

imatinib mesylate has been researched along with Sarcoma, Epithelioid in 92 studies

Research

Studies (92)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	60 (65.22)	29.6817
2010's	27 (29.35)	24.3611
2020's	5 (5.43)	2.80

Authors

Authors	Studies
Belgioia, L; Bertulli, R; Buscaglia, M; Catalano, F; Comandini, D; Grassi, M; Rebuzzi, SE; Satragno, C	1
Blay, JY; Lebellec, L; Penel, N; Robin, YM	1
Blay, JY; Casali, PG; Duffaud, F; Fumagalli, E; Gelderblom, H; Goldstein, D; Gronchi, A; Hartmann, JT; Hohenberger, P; Italiano, A; Judson, IR; Kotasek, D; Le Cesne, A; Litière, S; Marréaud, S; Martin-Broto, J; Penel, N; Rutkowski, P; Velasco, AP; Wardelmann, E; Zalcberg, JR	1
Pink, D; Reichardt, P	1
Eriksson, M; Joensuu, H	1
Aggarwal, A; Barwad, A; Dhamija, E; Panday, R; Rastogi, S; Sharma, A	1
Arribas, J; Carles, J; Díaz-Beveridge, R; Durán, J; Estival, A; García-Del-Muro, X; Hernández-Losa, J; Hindi, N; Jiménez, L; Landolfi, S; Lavernia, J; Manzano, A; Martínez-Marín, V; Pajares, I; Pericay, C; Rubió-Casadevall, J; Safont, MJ; Sebio, A; Serrano, C; Valverde, C; Vicente-Baz, D; Vivancos, A	1
Brich, S; Casale, A; Casali, PG; Cavalleri, A; Collini, P; Dinoi, G; Frezza, AM; Gronchi, A; Lo Vullo, S; Mariani, L; Messina, A; Morelli, D; Morosi, C; Palassini, E; Pilotti, S; Stacchiotti, S; Tamborini, E; Venturelli, E	1
Alsina, M; Llombart, B; Morgado-Carrasco, D; Requena, C; Sanmartín, O; Serra, C; Través, V	1
Antonescu, CR; Jain, S; Martz, J; Mosquera, JM; Popa, EC; Qin, L; Vahdat, LT	1
Jagannathan, JP; Kim, KW; Krajewski, KM; O'Regan, K; Ramaiya, NH; Shinagare, AB; Tirumani, SH	1
Antonescu, CR; Balachandran, VP; Besmer, P; Cavnar, MJ; Cohen, NA; Crawley, MH; DeMatteo, RP; Green, BL; Greer, JB; Kim, TS; Ocuin, LM; Popow, R; Rossi, F; Seifert, AM; Sorenson, EC; Zeng, S	1
Altinay, S; Kusaslan, R	1
Hayakumo, T; Ikura, Y; Iwai, Y; Kadota, C; Shigaki, Y	1
Blay, JY; Cassier, P; Dufresne, A; Heudel, P; Pissaloux, D; Ray-Coquard, I; Wang, Q	1
Movva, S; Norberg, SM	1
Aloia, TA; Brudvik, KW; Conrad, C; Cormier, JN; Feig, BW; Hunt, KK; Patel, SH; Roland, CL; Torres, KE; Vauthey, JN	1
Kato, S	1
Le Cesne, A; Patrikidou, A	1
Blay, JY; Debiec-Rychter, M; Gelderblom, H; Guchelaar, HJ; Judson, I; Peng, B; van Erp, N; van Glabbeke, M; Van Oosterom, A; Verweij, J	1
Baker, LH; Benjamin, RS; Chugh, R; Keohan, ML; Maki, RG; Meyers, PA; Myers, PA; Patel, SR; Priebat, DA; Reinke, DK; Samuels, BL; Thomas, DG; Wathen, JK	1
Campbell-Baird, C; Costa, L; Demers, L; Harvey, H; Kim, C; Lipton, A	1
Kamel, M; Kristiansen, G; Montemurro, M; Trojan, A	1
Emile, JF	1
Baker, LH; Verweij, J	1
Bonvalot, S; Bouzaiene, H; Rimareix, F	1
Dębiec-Rychter, M; Michej, W; Nowecki, Z; Ptaszynski, K; Ruka, W; Rutkowski, P; Symonides, M	1
Coindre, JM; Debiec-Rychter, M; Dewaele, B; Finalet-Ferreiro, J; Fletcher, CD; Floris, G; Guillou, L; Hogendoorn, PC; Marynen, P; Schöffski, P; Sciot, R; Vandenberghe, P; Vanspauwen, V; Wozniak, A	1
Delank, S; Eich, H; Wendtner, CM	1
Ando, M; Fujiwara, Y; Hiruma, T; Ishii, T; Kawai, A; Morioka, H; Mugishima, H; Ogose, A; Ozaki, T; Sugiura, H; Yokoyama, R	1
Bertz-Lepel, J; Pink, D; Reichardt, P	1
Coindre, JM	1
Gelderblom, H; van der Graaf, WT	1
Adenis, A; Bertucci, F; Blay, JY; Bui, BN; Chabaud, S; Chevreau, C; Cupissol, D; Domont, J; Duffaud, F; Le Cesne, A; Patrikidou, A; Pérol, D; Ray-Coquard, I; Rios, M	1
Bachanova, V; Begna, KH; Chen, D; Hanson, CA; Ketterling, RP; Viswanatha, DS	1
Posner, MC; Roggin, KK	1
Barr, FG; Bennicelli, JL	1
Blay, JY; Ray-Coquard, I	1
Campbell, SC; Hantel, A; Kash, J; Paner, GP; Sakamoto, K; Voelzke, BB; Waters, WB	1
Antonescu, CR; Awan, RA; Dixon, RH; Jhanwar, S; Maki, RG	1
Baker, L; Muler, JH; Zalupski, MM	1
Brugarolas, A; Calvo, E; Fernández, FJ; Forteza, J	1
Pindolia, VK; Zarowitz, BJ	1
Desai, J; George, S	1
De Mestier, P; Des Guetz, G; Pierga, JY	1
Demetri, G; Dimitrijevic, S; Fletcher, C; Joensuu, H; Roberts, P; Silberman, S	1
Patel, SR	2
Demetri, GD	1
Joensuu, H	2
Dimitrijevic, S; Donato di Paola, E; Dumez, H; Judson, IR; Nielsen, OS; Sciot, R; Stroobants, S; Van Glabbeke, M; van Oosterom, AT; Verweij, J	1
Baker, LH; Bekele, BN; Benjamin, RS; Champlin, RE; Thall, PF; Wathen, JK	1
Bickels, J; Inbar, M; Issakov, J; Kollender, Y; Meller, I; Merimsky, O; Schwartz, I	1
Blay, JY; Brown, M; di Paola, ED; Hogendoorn, PC; Judson, I; Le Cesne, A; Nielsen, OS; Radford, J; Rodenhuis, S; van der Graaf, W; van Oosterom, A; Verweij, J	1
Cole, P; Dimitrijevic, S; Dumez, H; Dupont, P; Goeminne, J; Martens, M; Mortelmans, L; Nuyts, J; Sciot, R; Seegers, M; Silberman, S; Stroobants, S; van den Borne, B; van Oosterom, A	1
de Jong, FA; Verweij, J	1
A'Hern, R; Burton, P; Hayes, AJ; Koban, MU; Mostyn-Jones, A; Thomas, JM	1
Gietema, JA; Jager, PL; van der Graaf, WT	1
Huelsmeyer, MK; Katayama, R; Kurzman, ID; Marr, AK; Thamm, DH; Vail, DM	1
Alcover, JB; Castillo, M; Mallofré, C; Mellado, B; Palacín, A; Petit, A	1
Fernberg, JO; Hall, KS	1
Verweij, J	1
Corless, CL; Heinrich, MC	2
Abad, M; Astudillo, A; Balbín, M; Blay, P; Braña, A; Buesa, JM; Campo, E; Freije, JM; García-García, J; Lacave, A; Losa, R; Marco, V; Miquel, R; Sierra, M	1
Chuman, H	1
Demetri, GD; Fletcher, CD; Ryan, DP; Titton, RL	1
di Paola, ED; Dimitrijevic, S; Dumez, H; Judson, I; Ma, P; Peng, B; Racine, A; Scurr, M; van Glabbeke, M; van Oosterom, A; Verweij, J	1
Blyweert, W; De Ridder, D; Debiec-Rychter, M; Ost, D; Sciot, R; Van der Aa, F; Van Oosterom, A; Van Poppel, H	1
Broaddus, RR; Caudell, JJ; Deavers, MT; Gershenson, DM; Lu, KH; Ramondetta, LM; Slomovitz, BM	1
She, R; Szakacs, J	1
Brennan, MF	1
Clark, MA; Fisher, C; Judson, I; Thomas, JM	1
Brody, LA; Brown, KT; Covey, AM; DeMatteo, R; Getrajdman, GI; Maluccio, MA; Schubert, J; Sofocleous, CT	1
Abbruzzese, JL; Benjamin, RS; Dupart, J; Hu, L; Hunt, K; Macapinlac, H; Pollock, R; Ramdas, L; Salvado, A; Taylor, E; Trent, JC; Zhang, W	1
Biolchini, F; Jovine, E; Lerro, FM; Martuzzi, F; Mastrangelo, L	1
Ban, S; Fujimura, M; Hirose, T; Ishihara, O; Mitsuhashi, T; Nakayama, M; Ogawa, F; Sakurai, S; Shimizu, M; Shimizu, Y	1
Alberti, L; Blay, JY; Cassier, PA; Dufresne, A; Fayette, J; Ranchere, D; Ray-Coquard, I	1
Guillén, C; Llombart, B; López-Guerrero, JA; Requena, C; Sanmartín, O; Serra, C	1
Eilber, FC; Federman, N; Tap, WD	1
Azim, HA; Elsedewy, E	1
Boyar, MS; Taub, RN	1
Czapiński-Tuzikiewicz, T; Dziki, AJ; Galbfach, PJ; Langner, EB; Spychalski, MI; Sroda, A	1
Andersson, LC; Capdeville, R; Demetri, GD; Dimitrijevic, S; Druker, B; Joensuu, H; Roberts, PJ; Sarlomo-Rikala, M; Silberman, S; Tervahartiala, P; Tuveson, D	1
Guilhot, F	1
Blay, JY; Cesne, AL; Ray-Coquard, I	1
Antman, KH; Savage, DG	1
Berman, JJ; Corless, C; Fletcher, CD; Gorstein, F; Lasota, J; Longley, BJ; Miettinen, M; O'Leary, TJ; Remotti, H; Rubin, BP; Shmookler, B; Sobin, LH; Weiss, SW	1
Dematteo, RP; Demetri, G; El-Rifai, WM; Heinrich, MC	1
El-Rifai, W; H L Sobin, L; Lasota, J; Miettinen, M	1

Reviews

40 review(s) available for imatinib mesylate and Sarcoma, Epithelioid

Article	Year
Overview of « druggable » alterations by histological subtypes of sarcomas and connective tissue intermediate malignancies. Critical reviews in oncology/hematology, 2020, Volume: 150 Topics: Antineoplastic Agents; Humans; Imatinib Mesylate; Molecular Targeted Therapy; Neoplasms, Connective Tissue; Sarcoma; Soft Tissue Neoplasms	2020
Guidelines for Diagnosis and Treatment of Cutaneous Sarcomas: Dermatofibrosarcoma Protuberans. Actas dermo-sifiliograficas, 2018, Volume: 109, Issue:10 Topics: Antineoplastic Agents; Combined Modality Therapy; Dermatofibrosarcoma; Humans; Imatinib Mesylate; Mohs Surgery; Neoplasm Grading; Neoplasm Staging; Oncogene Proteins, Fusion; Practice Guidelines as Topic; Radiotherapy, Adjuvant; Sarcoma; Skin Neoplasms	2018
Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to know. Cancer imaging : the official publication of the International Cancer Imaging Society, 2013, May-02, Volume: 13 Topics: Benzamides; Female; Humans; Imatinib Mesylate; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radiography; Sarcoma; TOR Serine-Threonine Kinases	2013
[Molecular biology of sarcoma and therapeutic choices]. Bulletin du cancer, 2015, Volume: 102, Issue:1 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Benzamides; Bone Neoplasms; Crizotinib; Denosumab; Dermatofibrosarcoma; Gastrointestinal Stromal Tumors; Gene Amplification; Gene Deletion; Giant Cell Tumor of Bone; Humans; Imatinib Mesylate; Indoles; Molecular Targeted Therapy; Phenylurea Compounds; Piperazines; Point Mutation; Prognosis; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Sarcoma; Sarcoma, Ewing; Sunitinib; Synovitis, Pigmented Villonodular; Translocation, Genetic	2015
Role of genetic and molecular profiling in sarcomas. Current treatment options in oncology, 2015, Volume: 16, Issue:5 Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Gene Expression Profiling; Humans; Imatinib Mesylate; Molecular Targeted Therapy; Precision Medicine; Prognosis; Sarcoma	2015
[Molecular targeted drugs for soft tissue sarcoma and neuroendocrine tumor]. Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73, Issue:8 Topics: Antibodies, Monoclonal, Humanized; Benzamides; Denosumab; Drug Discovery; Everolimus; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Indazoles; Indoles; Molecular Targeted Therapy; Neuroendocrine Tumors; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sarcoma; Sirolimus; Sorafenib; Sulfonamides; Sunitinib	2015
Key messages from the BFR14 trial of the French Sarcoma Group. Future oncology (London, England), 2017, Volume: 13, Issue:3 Topics: Antineoplastic Agents; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Disease Progression; France; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Staging; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Sarcoma; Treatment Outcome	2017
[Targeted therapies in soft-tissue and visceral sarcomas]. Annales de pathologie, 2009, Volume: 29 Spec No 1 Topics: Antineoplastic Agents; Benzamides; Chromosome Aberrations; Drug Delivery Systems; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mutation; Neoplasm Proteins; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Viscera	2009
Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrations. European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Benzamides; Cytotoxins; Dermatofibrosarcoma; Disease Progression; Gastrointestinal Stromal Tumors; Hemangioendothelioma; Hemangiosarcoma; Humans; Imatinib Mesylate; Leiomyosarcoma; Liposarcoma, Myxoid; Piperazines; Pyrimidines; Research Design; Sarcoma; Sarcoma, Synovial; Skin Neoplasms	2010
[Surgical news of soft tissue sarcomas, fibromatosis and GIST]. Bulletin du cancer, 2010, Volume: 97, Issue:6 Topics: Antineoplastic Agents; Benzamides; Fibromatosis, Aggressive; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Infusions, Intra-Arterial; Piperazines; Practice Guidelines as Topic; Pyrimidines; Retroperitoneal Neoplasms; Sarcoma; Surgical Flaps	2010
[Multimodality therapy concepts for soft tissue sarcomas]. Der Internist, 2010, Volume: 51, Issue:11 Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Combined Modality Therapy; Cross-Sectional Studies; Gastrointestinal Stromal Tumors; Humans; Hyperthermia, Induced; Imatinib Mesylate; Indoles; Neoadjuvant Therapy; Palliative Care; Piperazines; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Radiotherapy, Adjuvant; Sarcoma; Soft Tissue Neoplasms; Sunitinib	2010
[Systemic therapy of soft tissue sarcomas]. Der Pathologe, 2011, Volume: 32, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Drug Delivery Systems; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Survival Rate	2011
[Molecular biology of soft-tissue sarcomas]. Bulletin du cancer, 2010, Volume: 97, Issue:11 Topics: Antineoplastic Agents; Benzamides; Cyclin-Dependent Kinase 4; Drug Resistance, Neoplasm; Gene Amplification; Humans; Imatinib Mesylate; Mutation; Piperazines; Proto-Oncogene Proteins c-mdm2; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor alpha; Sarcoma; Translocation, Genetic	2010
New systemic therapy options for advanced sarcomas. Current treatment options in oncology, 2012, Volume: 13, Issue:3 Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Molecular Targeted Therapy; Neoplasm Staging; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sarcoma; Signal Transduction	2012
Chromosomal translocations and sarcomas. Current opinion in oncology, 2002, Volume: 14, Issue:4 Topics: Antineoplastic Agents; Benzamides; Diagnosis, Differential; Humans; Imatinib Mesylate; Immunotherapy; Oncogene Proteins, Fusion; Piperazines; Prognosis; Pyrimidines; Sarcoma; Translocation, Genetic	2002
Gastrointestinal stromal tumor: involvement in urologic patients and recent therapeutic advances. Urology, 2002, Volume: 60, Issue:2 Topics: Antigens, Neoplasm; Antineoplastic Agents; Benzamides; Carcinoma, Renal Cell; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Piperazines; Prostatic Neoplasms; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma	2002
Gastrointestinal stromal tumors: chemotherapy and imatinib. Current oncology reports, 2002, Volume: 4, Issue:6 Topics: Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Stomach Neoplasms; Stromal Cells; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
Imatinib mesylate, the first molecularly targeted gene suppressor. Pharmacotherapy, 2002, Volume: 22, Issue:10 Topics: Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Neoplasm; Food-Drug Interactions; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Patient Education as Topic; Piperazines; Pyrimidines; Sarcoma; Stromal Cells	2002
Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitors. Current treatment options in oncology, 2002, Volume: 3, Issue:6 Topics: Antineoplastic Agents; Benzamides; Combined Modality Therapy; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma	2002
[At last, an effective therapy for non-differentiated GI sarcomas (gastro intestinal stromal tumor)]. Journal de chirurgie, 2002, Volume: 139, Issue:5 Topics: Adult; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Drug Resistance, Neoplasm; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunohistochemistry; Leiomyosarcoma; Middle Aged; Mutation; Piperazines; Prognosis; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Stomach; Stomach Neoplasms; Time Factors	2002
Management of malignant gastrointestinal stromal tumours. The Lancet. Oncology, 2002, Volume: 3, Issue:11 Topics: Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Combined Modality Therapy; Diagnosis, Differential; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunohistochemistry; Mesoderm; Oncogene Proteins; Piperazines; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma	2002
Developing therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas. Expert opinion on investigational drugs, 2002, Volume: 11, Issue:12 Topics: Antineoplastic Agents; Benzamides; Camptothecin; Dacarbazine; Deoxycytidine; Dioxoles; Gemcitabine; Humans; Imatinib Mesylate; Irinotecan; Isoquinolines; Piperazines; Pyrimidines; Sarcoma; Temozolomide; Tetrahydroisoquinolines; Trabectedin	2002
Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development. Hematology/oncology clinics of North America, 2002, Volume: 16, Issue:5 Topics: Antineoplastic Agents; Benzamides; Drug Design; Enzyme Inhibitors; Female; Forecasting; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Middle Aged; Multicenter Studies as Topic; Neoplasm Proteins; Oncogene Proteins, Fusion; Phosphorylation; Piperazines; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Sequence Deletion; Signal Transduction	2002
[Tyrosine kinase inhibitor as a targeted therapy for GIST tumors]. Duodecim; laaketieteellinen aikakauskirja, 2002, Volume: 118, Issue:22 Topics: Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Leiomyosarcoma; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Treatment Outcome	2002
Role of imatinib mesylate (Gleevec/Glivec) in gastrointestinal stromal tumors. Expert review of anticancer therapy, 2003, Volume: 3, Issue:6 Topics: Animals; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Sarcoma; Stromal Cells	2003
Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience. Acta orthopaedica Scandinavica. Supplementum, 2004, Volume: 75, Issue:311 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chemotherapy, Adjuvant; Disease-Free Survival; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Meta-Analysis as Topic; Piperazines; Prospective Studies; Protein-Tyrosine Kinases; Pyrimidines; Randomized Controlled Trials as Topic; Registries; Remission Induction; Sarcoma; Scandinavian and Nordic Countries; Soft Tissue Neoplasms	2004
KIT and PDGF as targets. Cancer treatment and research, 2004, Volume: 120 Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Piperazines; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Sarcoma; Soft Tissue Neoplasms	2004
Targeting mutant kinases in gastrointestinal stromal tumors: a paradigm for molecular therapy of other sarcomas. Cancer treatment and research, 2004, Volume: 120 Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Mutation; Piperazines; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Sarcoma; Soft Tissue Neoplasms	2004
[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Taxoids	2004
Soft tissue sarcoma: advances in understanding and management. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2005, Volume: 3, Issue:3 Topics: Age Distribution; Benzamides; Chemotherapy, Adjuvant; Genetic Predisposition to Disease; Humans; Imatinib Mesylate; Piperazines; Prognosis; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma; Survival Rate	2005
Soft-tissue sarcomas in adults. The New England journal of medicine, 2005, Aug-18, Volume: 353, Issue:7 Topics: Adult; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiotherapy; Sarcoma	2005
Emerging drugs for the treatment of soft tissue sarcomas. Expert opinion on emerging drugs, 2007, Volume: 12, Issue:1 Topics: Antineoplastic Agents; Benzamides; Dacarbazine; Doxorubicin; Gastrointestinal Stromal Tumors; Humans; Ifosfamide; Imatinib Mesylate; Indoles; Piperazines; Pyrimidines; Pyrroles; Sarcoma; Sunitinib	2007
[Dermatofibrosarcoma protuberans]. Actas dermo-sifiliograficas, 2007, Volume: 98, Issue:2 Topics: Antigens, CD34; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 22; Combined Modality Therapy; Dermatofibrosarcoma; Drug Design; Humans; Imatinib Mesylate; Mohs Surgery; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Piperazines; Prognosis; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Ring Chromosomes; Sarcoma; Skin Neoplasms; Translocation, Genetic	2007
Targeted therapies for soft-tissue sarcomas. Expert review of anticancer therapy, 2007, Volume: 7, Issue:5 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Benzamides; Heat-Shock Proteins; Humans; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sarcoma; Signal Transduction; Sirolimus	2007
Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature. Onkologie, 2007, Volume: 30, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Cisplatin; Dendritic Cells, Follicular; Deoxycytidine; Follow-Up Studies; Gemcitabine; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome	2007
Molecular pathobiology of gastrointestinal stromal sarcomas. Annual review of pathology, 2008, Volume: 3 Topics: Benzamides; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Indoles; Mutation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Sarcoma; Sunitinib	2008
[STI571 and gastro intestinal stromal tumors]. Bulletin du cancer, 2001, Volume: 88, Issue:7 Topics: Antineoplastic Agents; Benzamides; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Sarcoma	2001
Imatinib mesylate--a new oral targeted therapy. The New England journal of medicine, 2002, Feb-28, Volume: 346, Issue:9 Topics: Administration, Oral; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Drug Resistance; Gastrointestinal Neoplasms; Humans; Hydroxyurea; Imatinib Mesylate; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Sarcoma	2002
Diagnosis of gastrointestinal stromal tumors: A consensus approach. Human pathology, 2002, Volume: 33, Issue:5 Topics: Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Stromal Cells	2002
Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Human pathology, 2002, Volume: 33, Issue:5 Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Neoplasms; Genetic Markers; Humans; Imatinib Mesylate; Immunohistochemistry; Loss of Heterozygosity; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Stromal Cells	2002

Trials

10 trial(s) available for imatinib mesylate and Sarcoma, Epithelioid

Article	Year
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sar Annals of oncology : official journal of the European Society for Medical Oncology, 2021, Volume: 32, Issue:4 Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Italy; Neoplasm Recurrence, Local; Sarcoma	2021
Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study. Cancer, 2018, 10-15, Volume: 124, Issue:20 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chordoma; Disease Progression; Everolimus; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Male; Middle Aged; Sarcoma; Skull Base Neoplasms; Spinal Neoplasms; Survival Analysis	2018
Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jul-01, Volume: 27, Issue:19 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bayes Theorem; Benzamides; Disease-Free Survival; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Middle Aged; Piperazines; Polymerase Chain Reaction; Pyrimidines; Sarcoma; Treatment Outcome; Young Adult	2009
Phase I trial of zoledronic acid + imatinib mesylate (Gleevec) in patients with bone metastases. American journal of clinical oncology, 2010, Volume: 33, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imatinib Mesylate; Imidazoles; Kidney Neoplasms; Male; Maximum Tolerated Dose; Neoplasm Staging; Piperazines; Prognosis; Prostatic Neoplasms; Pyrimidines; Sarcoma; Survival Rate; Treatment Outcome; Zoledronic Acid	2010
Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2010, Volume: 15, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; Child; Disease-Free Survival; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Sarcoma; Young Adult	2010
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:4 Topics: Adult; Aged; Benzamides; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Prospective Studies; Pyrimidines; Sarcoma; Treatment Outcome	2013
Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group. European journal of cancer (Oxford, England : 1990), 2002, Volume: 38 Suppl 5 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms, Connective Tissue; Piperazines; Pyrimidines; Sarcoma; Stromal Cells; Treatment Outcome	2002
Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:14 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Disease Progression; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Survival Analysis; Treatment Outcome	2003
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:14 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Prospective Studies; Pyrimidines; Radiopharmaceuticals; Sarcoma; Survival Analysis; Tomography, Emission-Computed; Treatment Failure	2003
Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET. Nuclear medicine communications, 2004, Volume: 25, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Treatment Outcome	2004

Other Studies

42 other study(ies) available for imatinib mesylate and Sarcoma, Epithelioid

Article	Year
Multiple systemic treatment options in a patient with malignant tenosynovial giant cell tumour. Anti-cancer drugs, 2020, Volume: 31, Issue:1 Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Giant Cell Tumor of Tendon Sheath; Humans; Imatinib Mesylate; Indazoles; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma; Soft Tissue Neoplasms; Sulfonamides	2020
[Treatment of soft tissue sarcomas including GIST - Update 2021]. Deutsche medizinische Wochenschrift (1946), 2021, Volume: 146, Issue:3 Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Phenylurea Compounds; Pyridines; Sarcoma; Sunitinib	2021
Adjuvant imatinib for GIST: duration likely matters. Annals of oncology : official journal of the European Society for Medical Oncology, 2021, Volume: 32, Issue:4 Topics: Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Italy; Piperazines; Sarcoma	2021
Advanced Dermatofibrosarcoma Protuberans Treatment With Imatinib: Experience From a Dedicated Sarcoma Medical Oncology Clinic in India. Journal of global oncology, 2018, Volume: 4 Topics: Adult; Dermatofibrosarcoma; Humans; Imatinib Mesylate; India; Medical Oncology; Middle Aged; Sarcoma; Young Adult	2018
Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib. The oncologist, 2019, Volume: 24, Issue:5 Topics: Adult; Antineoplastic Agents; Case-Control Studies; Disease Progression; Drug Resistance, Neoplasm; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Prognosis; Progression-Free Survival; Sarcoma; Time Factors	2019
High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-10, Volume: 31, Issue:11 Topics: Aged; Benzamides; Dasatinib; Diagnosis, Differential; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Thiazoles; Vimentin	2013
KIT oncogene inhibition drives intratumoral macrophage M2 polarization. The Journal of experimental medicine, 2013, Dec-16, Volume: 210, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Benzamides; CCAAT-Enhancer-Binding Proteins; Cell Proliferation; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Inflammation; Macrophages; Male; Mice; Middle Aged; Mutation; Phenotype; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma	2013
Gastrointestinal autonomic nerve tumour of jejunum presenting as a perforated mass. JPMA. The Journal of the Pakistan Medical Association, 2014, Volume: 64, Issue:4 Topics: Abdomen, Acute; Aged; Antineoplastic Agents; Autonomic Nervous System Diseases; Benzamides; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Jejunal Neoplasms; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sarcoma	2014
Unexpected DOG-1 immunoreactivity in sarcomatous carcinoma of the liver: a diagnostic pitfall. Pathology, 2014, Volume: 46, Issue:6 Topics: Aged; Anoctamin-1; Antineoplastic Agents; Autopsy; Bile Duct Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Chloride Channels; Diagnosis, Differential; Fatal Outcome; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Male; Neoplasm Proteins; Sarcoma; Tomography, X-Ray Computed; Ultrasonography	2014
Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2015, Volume: 19, Issue:8 Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Databases, Factual; Disease-Free Survival; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leiomyosarcoma; Liver Neoplasms; Male; Metastasectomy; Middle Aged; Retroperitoneal Neoplasms; Retrospective Studies; Sarcoma; Survival Rate; Young Adult	2015
Effect of cigarette smoking on imatinib in patients in the soft tissue and bone sarcoma group of the EORTC. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Dec-15, Volume: 14, Issue:24 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Bone Neoplasms; Female; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Retrospective Studies; Sarcoma; Smoking; Soft Tissue Neoplasms	2008
Successful PDGFR-{alpha}/{beta} targeting with imatinib in uterine sarcoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:11 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Delivery Systems; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sarcoma; Uterine Neoplasms	2009
Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection. Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:3 Topics: Antineoplastic Agents; Benzamides; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 22; Collagen Type I; Collagen Type I, alpha 1 Chain; Combined Modality Therapy; Dermatofibrosarcoma; Disease-Free Survival; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Male; Middle Aged; Oncogene Proteins, Fusion; Piperazines; Proto-Oncogene Proteins c-sis; Pyrimidines; Retrospective Studies; Sarcoma; Skin Neoplasms; Treatment Outcome	2011
Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma. Cancer research, 2010, Sep-15, Volume: 70, Issue:18 Topics: Adult; Aged; Benzamides; Comparative Genomic Hybridization; Dasatinib; ErbB Receptors; Female; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Male; Middle Aged; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sarcoma; Thiazoles; Tunica Intima; Vascular Neoplasms	2010
A case of nonleukemic myeloid sarcoma with FIP1L1-PDGFRA rearrangement: an unusual presentation of a rare disease. The American journal of surgical pathology, 2013, Volume: 37, Issue:1 Topics: Adult; Antineoplastic Agents; Benzamides; Bone Marrow Cells; Bone Marrow Neoplasms; Gene Rearrangement; Humans; Imatinib Mesylate; Immunophenotyping; Male; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Remission Induction; Sarcoma; Treatment Outcome	2013
Modern treatment of gastric gastrointestinal stromal tumors. World journal of gastroenterology, 2012, Dec-14, Volume: 18, Issue:46 Topics: Antineoplastic Agents; Benzamides; Endoscopy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Minimally Invasive Surgical Procedures; Neoadjuvant Therapy; Piperazines; Prognosis; Pyrimidines; Recurrence; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2012
[Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002]. Bulletin du cancer, 2002, Volume: 89, Issue:6 Topics: Antineoplastic Agents; Benzamides; Dermatofibrosarcoma; Florida; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Skin Neoplasms	2002
Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. International journal of cancer, 2002, Aug-20, Volume: 100, Issue:6 Topics: Adult; Antineoplastic Agents; Benzamides; Dermatofibrosarcoma; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Recurrence; Sarcoma; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2002
[Effect of STI-571, a c-kit tyrosine kinase inhibitor, in mestastasic gastrointestinal tumor]. Medicina clinica, 2002, Sep-28, Volume: 119, Issue:10 Topics: Adult; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma	2002
Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes. Statistics in medicine, 2003, Mar-15, Volume: 22, Issue:5 Topics: Antineoplastic Agents; Bayes Theorem; Benzamides; Bone Marrow Transplantation; Busulfan; Clinical Trials, Phase II as Topic; Disease Progression; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Piperazines; Pyrimidines; Research Design; Sarcoma; Treatment Outcome; Vidarabine	2003
Lack of c-kit overexpression in soft tissue sarcomas. The Israel Medical Association journal : IMAJ, 2003, Volume: 5, Issue:2 Topics: Aged; Benzamides; Humans; Imatinib Mesylate; Infant; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma	2003
Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma. The British journal of surgery, 2004, Volume: 91, Issue:2 Topics: Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunoassay; Piperazines; Platelet Count; Prospective Studies; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Vascular Endothelial Growth Factor A	2004
Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma. Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cat Diseases; Cats; Imatinib Mesylate; Mice; Mice, Nude; Neoplasms, Experimental; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Sarcoma; Signal Transduction; Transplantation, Heterologous; Tumor Cells, Cultured; Vaccines	2004
C-kit expression in sarcomatoid renal cell carcinoma: potential therapy with imatinib. The Journal of urology, 2004, Volume: 171, Issue:6 Pt 1 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Carcinoma, Renal Cell; Female; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Kidney Neoplasms; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma	2004
Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jun-15, Volume: 10, Issue:12 Pt 1 Topics: Benzamides; Blotting, Western; Gastrointestinal Neoplasms; Gene Expression Regulation; Humans; Imatinib Mesylate; Immunohistochemistry; Isoenzymes; Mesoderm; Neoplasms; Oligonucleotide Array Sequence Analysis; Piperazines; Protein Isoforms; Protein Kinase C; Protein Kinase C-theta; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma; Stromal Cells; T-Lymphocytes; Transcription, Genetic	2004
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-2004. A 68-year-old man with a large retroperitoneal mass. The New England journal of medicine, 2004, Oct-21, Volume: 351, Issue:17 Topics: Aged; Antigens, CD34; Antineoplastic Agents; Benzamides; Biopsy, Needle; Humans; Imatinib Mesylate; Liver; Male; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Retroperitoneal Neoplasms; Sarcoma; Stromal Cells; Tomography, X-Ray Computed	2004
Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group. Cancer chemotherapy and pharmacology, 2005, Volume: 55, Issue:4 Topics: Antineoplastic Agents; Benzamides; Body Weight; Female; Gastrointestinal Stromal Tumors; Granulocytes; Hemoglobins; Humans; Imatinib Mesylate; Leukocyte Count; Male; Piperazines; Pyrimidines; Retrospective Studies; Sarcoma; Time Factors	2005
Gastrointestinal stromal tumor of the prostate. Urology, 2005, Volume: 65, Issue:2 Topics: Acute Disease; Amino Acid Substitution; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Mutation, Missense; Neoplasm Proteins; Piperazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiography; Sarcoma; Urinary Retention; Weight Loss	2005
Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas. Applied immunohistochemistry & molecular morphology : AIMM, 2005, Volume: 13, Issue:2 Topics: Antineoplastic Agents; Benzamides; Female; Gene Expression Profiling; Humans; Imatinib Mesylate; Immunohistochemistry; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Sarcoma; Uterine Neoplasms	2005
Carcinosarcoma of the liver: a case report and review of the literature. Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:6 Topics: Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Carcinosarcoma; Diagnosis, Differential; Fatal Outcome; Female; Hepatorenal Syndrome; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Piperazines; Pyrimidines; Sarcoma	2005
Treatment of metastatic sarcoma to the liver with bland embolization. Cancer, 2006, Oct-01, Volume: 107, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Chemoembolization, Therapeutic; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Piperazines; Polyvinyl Alcohol; Pyrimidines; Sarcoma; Treatment Outcome	2006
Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor. Cancer, 2006, Oct-15, Volume: 107, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Survival; Gastrointestinal Stromal Tumors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Proteins; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiography; Sarcoma; Up-Regulation	2006
Malignant gastrointestinal stromal neoplasm. Surgery, 2006, Volume: 140, Issue:5 Topics: Adult; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Pyrimidines; Sarcoma	2006
KIT-negative undifferentiated endometrial sarcoma with the amplified epidermal growth factor receptor gene showing a temporary response to imatinib mesylate. Annals of diagnostic pathology, 2007, Volume: 11, Issue:1 Topics: Antineoplastic Agents; Benzamides; Biopsy; Cell Differentiation; DNA, Neoplasm; Endometrial Neoplasms; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma	2007
New strategies for treating GIST when imatinib fails. Cancer investigation, 2007, Volume: 25, Issue:5 Topics: Antineoplastic Agents; Benzamides; Disease Progression; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Sarcoma; Tomography, X-Ray Computed; Treatment Failure	2007
[Gastrointestinal stromal tumors (GIST)]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2007, Volume: 60, Issue:3-4 Topics: Aged; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Sarcoma; Treatment Outcome	2007
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. The New England journal of medicine, 2001, Apr-05, Volume: 344, Issue:14 Topics: Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Female; Fluorodeoxyglucose F18; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma; Stomach Neoplasms; Stromal Cells; Tomography, Emission-Computed	2001
[Anti-tyrosine kinase: the beginning of molecular therapies of cancer and initial results]. Bulletin du cancer, 2001, Volume: 88, Issue:7 Topics: Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oncogene Proteins, Fusion; Philadelphia Chromosome; Piperazines; Prognosis; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Stomach Neoplasms; Treatment Outcome	2001
Cancer treatment. New drugs, new hope. Harvard health letter, 2001, Volume: 26, Issue:9 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma	2001
Treatment of inoperable gastrointestinal stromal tumor (GIST) with Imatinib (Glivec, Gleevec). Medizinische Klinik (Munich, Germany : 1983), 2002, Jan-15, Volume: 97 Suppl 1 Topics: Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Stromal Cells; Treatment Outcome	2002
Systemic therapy for advanced soft-tissue sarcomas. Current oncology reports, 2002, Volume: 4, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Doxorubicin; Gastrointestinal Neoplasms; Humans; Ifosfamide; Imatinib Mesylate; Piperazines; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Survival Rate	2002
Clinical management of gastrointestinal stromal tumors: before and after STI-571. Human pathology, 2002, Volume: 33, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Chemotherapy, Adjuvant; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Mutation; Piperazines; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Stromal Cells; Survival Analysis; Survival Rate	2002